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Abstract
Malaria has had the largest impact of any infectious disease on shaping the human genome, exerting enormous selective
pressure on genes that improve survival in severe malaria infections. Modern humans originated in Africa and lost skin
melanization as they migrated to temperate regions of the globe. Although it is well documented that loss of melanization
improved cutaneous Vitamin D synthesis, melanin plays an evolutionary ancient role in insect immunity to malaria and in
some instances melanin has been implicated to play an immunoregulatory role in vertebrates. Thus, we tested the
hypothesis that melanization may be protective in malaria infections using mouse models. Congenic C57BL/6 mice that
differed only in the gene encoding tyrosinase, a key enzyme in the synthesis of melanin, showed no difference in the clinical
course of infection by Plasmodium yoelii 17XL, that causes severe anemia, Plasmodium berghei ANKA, that causes severe
cerebral malaria or Plasmodium chabaudi AS that causes uncomplicated chronic disease. Moreover, neither genetic
deficiencies in vitamin D synthesis nor vitamin D supplementation had an effect on survival in cerebral malaria. Taken
together, these results indicate that neither melanin nor vitamin D production improve survival in severe malaria.
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Introduction
Melanins are pigments that have evolved over 500 million
years and that are present in animals, microorganisms and
plants. In flies and mosquitoes melanization of pathogens is part
of the innate immune response and it is correlated with
resistance to infection [1,2]. In animals, melanin is produced
by melanocytes, that are present in a variety of tissues, including
skin, uveal tract, brain and the peritoneum [3]. The low level of
melanization in the skin of humans living in temperate climates
of the globe is in large part due to the fact that melanin pigments
absorb and scatter the UVB wavelengths that catalyze the
conversion of 7-dehydrocholesterol to pre-Vitamin D3, the
precursor of Vitamin D3 in the skin [4,5]. In fact, individuals
with marked skin melanization frequently require 10–20 times
longer exposure to sunlight than those of lighter pigmentation to
promote adequate synthesis of vitamin D3 [4,6]. Vitamin D
deficiency can exert strong selective pressure by causing severe
deformation of the pelvis in women, leading to increased
perinatal morbidity and mortality, or increasing the susceptibility
to infections and death in children [7]. The pressure for skin
melanization in tropical regions, on the other hand, can be
explained by the advantage of melanized individuals to
withstand prolonged sun exposure, although a rigorous link of
melanization with an increase in fitness in mammals has not
been established [3]. Interestingly, dark colors are attractive to
Aedes aegyptii, the mosquito vector of dengue and yellow fever,
and Culex fatigans, the mosquito vector of filarial worms, but not
for anopheline mosquitoes, the mosquito vectors of malaria,
which find light colors more attractive [8]. In this regard skin
melanization can be either advantageous or detrimental,
depending on the disease.
In addition, both melanin and vitamin D have been suggested
to have potential immunoregulatory functions. Melanin has been
shown in some circumstances to have antioxidant [9,10], anti-
inflammatory [11], and immunoregulatory functions in innate
immune responses, with melanocytes participating in phagocyto-
sis [12] and inflammation [13,14,15]. This observation led to the
suggestion that an additional function of melanin in the skin is to
promote immune responses to infections [3,16,17]. In birds,
melanin levels have been shown to influence the magnitude of
antibody and cellular responses [18]. In addition, vitamin D
deficiencies have been reported to increase [19,20] and to
decrease resistance to infection [21,22]. Although in experiments
vitamin D inhibits plasmodium growth in vitro [23], in malaria
infections neither VDR gene polymorphisms or vitamin D levels
correlate with infection [24]. On the other hand, vitamin D
deficiency has been shown to be a risk factor for the development
of autoimmune diseases including multiple sclerosis [25,26,27,28]
and systemic lupus erythematosus (SLE) [29,30,31]. SLE is eight
to ten times more prevalent in women of African as compared to
European descent and recently, we provided evidence in a mouse
model of SLE that SLE susceptibility genes that result in
hyperimmune activation are protective in cerebral malaria but
not against severe anemia [32]. These results suggested that the
higher incidence of SLE in African Americans may be a
consequence of the beneficial effects of SLE susceptibility genes
in malaria-endemic areas.
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immunoregulatory roles led us to the hypothesis that melanin
or vitamin D production may have been selected for in Africans
in part due to a protective role in malaria. To test this hypothesis,
we compared the course of malaria infections in wild type and
albino B6(Cg)-Tyrc-2J/J mice (B6.Tyr
2/2 mice) that have
mutations in the Tyr gene, that encodes tyrosinase, the same
gene that is mutated in type I human oculocutaneous albinism.
Tyrosinase is the key enzyme in mammalian melanin biosyn-
thesis that catalyzes the conversion of tyrosine to dopa, the
dehydrogenation of dopa to dopaquinone, and the conversion of
5,6-dihidroxyindile to melanochrome, which is the direct
precursor of melanin [33]. Consequently, the absence of
tyrosinase ablates completely the synthesis of the major body
melanins, pheomelanin and eumelanin. We also tested whether
vitamin D had an effect on the course of malaria infections in
mice.
Results
Melanization does not protect against malaria-induced
severe anemia
C57BL/6 (B6) mice and tyrosinase deficient B6 (B6.Tyr
2/2)
mice were infected with the lethal strain P. yoelii 17XL by injection
of 10
4 infected red blood cells i.p. Mice were followed daily to
evaluate parasitemia, body weight, temperature, clinical status,
hemoglobin concentration and survival (Figure 1). We also
determined the hematocrit, white blood cell differential count
and platelets count, on day 0 and day 3 following infection (Figure
S1). Infected B6.Tyr
2/2 mice had higher white blood cell counts,
less anemia and higher lymphocyte counts on day 3 as compared
to B6 mice. Despite these differences, we observed no difference in
the survival of the B6 and B6.Tyr
2/2 mice following P. yoelii 17XL
infections. The majority of B6 and B6.Tyr
2/2 mice died of the
infection within 8–9 days and mice from the two groups showed a
Figure 1. Effect of melanization in severe malaria anemia. (A) The percent of B6.Tyr2/2 and B6 P. yoelii 17XL infected mice that survived
over time is given in Kaplan-Meier curves. Death was defined as a parasitemia $60%, moribundity or death (P=0.64). (B) Parasitemias, determined
by GIEMSA stained smears of tail blood, are given for B6.Tyr2/2 and B6 infected mice over time. (C) Clinical scores determined by the modified
SNAP scoring system are given. (D) Hemoglobin concentrations of B6.Tyr2/2 and B6 infected mice are given. (E) Body temperature determined at
the tail skin for both B6.Tyr2/2 and B6 infected mice over time are given. Data showed represents the mean of 10 animals and bars represent the
SEM.
doi:10.1371/journal.pone.0029493.g001
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of parasitemia appear different between the two groups after day 7
but these differences are not statistically significant as only one
mouse in each group survived beyond day 7.
Melanization does not protect against cerebral malaria
P. berghei ANKA is an established model of mouse cerebral
malaria (CM) that reproduces reasonably well the pathological
features of human CM. P. berghei infections are lethal in mice
resulting in early death (by day 6–12) in susceptible B6 strains due
to CM or, in late death (between days 14 and 21) in resistant
strains due to severe anemia [34,35]. B6 and B6.Tyr
2/2 mice
were infected with P. berghei ANKA by injection of 10
6 infected red
blood cells, i.p. All mice, both B6 and B6.Tyr
2/2, died before day
10 and developed signs of CM (Figure 2). No differences in
survival were observed between the groups. In addition, B6 and
B6.Tyr
2/2 mice showed no significant differences in parasitemia,
hemoglobin levels, body temperature or cytokine levels (Figure S2)
during the course of the infection. Thus, it appears that the ability
to produce melanin is not protective against severe CM.
Melanization does not protect against chronic malaria
infection
To determine the effect of melanin deficiency on the course of a
chronic malarial infection we infected B6 and B6.Tyr
2/2 mice
with P. chabaudi AS by injection of mice with 10
6 infected red blood
cells. P. chabaudi AS causes a biphasic infection characterized
initially by acute parasitemia that peaks around day 7, followed by
Figure 2. Effect of melanization on cerebral malaria. (A) The percent of B6.Tyr2/2 and B6 P. berghei ANKA infected mice that survived over
time is given in Kaplan-Meier curves. Death was defined as a parasitemia $60%, moribundity or death (P=0.71). (B) Parasitemias, determined by
GIEMSA stained smears of tail blood, are given for B6.Tyr2/2 and B6 infected mice over time. (C) Clinical scores determined by the modified SNAP
scoring system are given. (D) Hemoglobin concentrations of B6.Tyr2/2 and B6 infected mice are given. (E) Body temperature determined at the tail
skin for both B6.Tyr2/2 and B6 infected mice over time are given. Data showed represents the mean of 10 animals and bars represent the SEM.
doi:10.1371/journal.pone.0029493.g002
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phase is controlled both by an innate system response as well as a
Th1 response [36,37] while the control and clearance of the
chronic blood infection during the second phase requires both
TH1 and TH2 CD4
+ cells and B cells [36,38]. We followed the P.
chabaudi infected mice for 21 days and observed no difference
between B6 and B6.Tyr
2/2 mice in all parameters analyzed
including survival, parasitemia, clinical score, hemoglobin levels,
body temperature and leukocyte, neutrophil and lymphocyte
numbers. (Figure 3, Figure S3). Thus, we concluded that the
ability to produce melanin did not affect the course of chronic
malaria infections.
Melanin treatment decreases parasitemia but does not
protect against cerebral malaria
Previous studies have shown that melanin in high doses can
affect the secretion of multiple cytokines, including TNF-a, IL-1b,
IL-6 and GM-CSF [39]. To investigate the effects of high doses of
melanin on the course of malaria CM infections, we treated P.
berghei ANKA infected B6.Tyr
2/2 mice with daily doses of melanin
(25 mg/kg) in saline i.p. or with saline alone. B6.Tyr
2/2 mice
receiving melanin showed a delayed increased in parasitemia
(P,0.05) and better clinical scores but did not better survive the
infection as compared to controls B6.Tyr
2/2 mice receiving saline
(P=0.58) (Figure 4). On day five post-infection, melanin treated
mice had higher platelet counts than controls (P,0.001) (Figure
S4), and the number of platelets correlated positively with survival
(Spearman Rho=0.64, p=0.002). On the other hand, melanin
treatment caused animals to have a steeper decrease in
hemoglobin levels, especially from day 3 to day 5 post-infection
(P,0.05). The fact that melanin treated mice did not survive the
infection any better than control B6 mice suggests that, albeit
somewhat beneficial, melanin treatment is not sufficient to change
the course of the disease in mice (Figure 4).
Vitamin D does not protect against cerebral malaria
Because skin melanization is an important factor in cutaneous
vitamin D biosynthesis, we tested if vitamin D deficiency
influenced the pathogenesis of cerebral malaria. We also
supplemented the diets of mice with vitamin D injections i.p.
every other day (0.5 mg/kg), starting 3 days before infection with P.
berghei ANKA. We did not observe any difference in survival
between treated and untreated mice with all mice dying by day 8
(Figure 5A). Also, we did not observe any differences in
parasitemia or body temperature during the course of infection
suggesting that vitamin D, at the levels used in this study, does not
influence the immune response to malaria (Figure 5B and 5E).
Animals receiving vitamin D injections had better clinical scores at
days 6 and 7 post infection and had higher hemoglobin levels than
controls but this effect was apparently not enough to reduce
mortality (P=0.76).
We also followed the course of P. berghei ANKA infections in
wild type B6 mice and in mice deficient in the vitamin D receptor
(VDR) and B6.VDR
2/2 mice. Because B6.VDR
2/2 knockout
Figure 3. Effect of melanization on chronic malaria infection. (A) Parasitemias, determined by GIEMSA stained smears of tail blood, are given
for B6.Tyr2/2 and B6 P. chabaudi AS infected mice over time. (B) Clinical scores determined by the modified SNAP scoring system, are given.
(C) Hemoglobin concentrations of B6.Tyr2/2 and B6 infected mice are given. (D) Body temperature determined at the tail skin for both B6.Tyr2/2
and B6 infected mice over time are given. Data showed represents the mean of 10 animals and bars represent the SEM.
doi:10.1371/journal.pone.0029493.g003
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death, we kept wild type B6 mice on the same diet. We observed
no difference in the course of disease in B6 and B6.VDR
2/2 mice
(Figure 6). Most B6 and B6.VDR
2/2 mice died within 9–10 days
of infection and showed similar parasitemias, clinical scores,
hemoglobin levels and body temperatures.
Discussion
Our results provide evidence that melanization does not
improve survival in severe malaria. Melanization did not improve
survival against parasites that cause either CM or severe anemia
and does not affect the course of chronic infections. Our data also
suggests that neither vitamin D treatment nor vitamin D receptor
deficiency affect the progression of cerebral malaria caused by P.
berghei ANKA infections. Therefore the data suggest that melanin,
neither directly nor through its indirect effect on vitamin D
synthesis, improves survival in severe malaria in mice. High doses
of vitamin D have been reported to decreased parasite growth and
survival in vitro [40] but we did not observe similar effects when
treating animals with lower doses. This is in agreement with
previous studies in humans showing a lack of association between
polymorphisms on the VDR gene and malaria infection [19].
Nevertheless, because we only tested the effects of one dose of
vitamin D3 (and not of other forms) one cannot exclude
completely an effect of vitamin D on malaria.
We also tested the effect of high doses of melanin on the
progression of CM. Although the dose used was previously shown
to reduce LPS induced TNF-a production [39] and we showed
that high doses of melanin delayed increases in parasitemia and
improved clinical scores, melanin treatment was not sufficient to
increase survival in CM. The effect in parasitemia and clinical
scores can be potentially explained by direct anti-parasite effect of
melanin (as observed in mosquitoes) or by its free radical
scavenging properties. CM is a complex disease caused in part
by excessive free radicals generated as a response to free iron and
hemoglobin [41,42,43] and, under certain conditions, free radical
scavengers can block some of the deleterious effects of malaria
[44,45]. Interestingly, melanin treatment prevented the thrombo-
cytopenia that was observed in B6 mice by day 5 post-infection.
Changes in platelet counts are also common in human malaria
infection, and the extent of reduction is a predictor of clinical
outcome and severity of malarial infection in children [46].
Platelets are involved in the pathogenesis of cerebral malaria as
Figure 4. Effect of melanin treatment on cerebral malaria. (A) The percent of melanin treated and untreated B6.Tyr2/2 P. berghei ANKA
infected mice that survived over time is given in Kaplan-Meier curves. Death was defined as a parasitemia $60%, moribundity or death (P=0.33). (B)
Parasitemias, determined by GIEMSA stained smears of tail blood, are given for B6.Tyr2/2 treated and untreated infected mice over time. (C) Clinical
scores determined by the modified SNAP scoring system are given. (D) Hemoglobin concentrations of B6. Tyr2/2 treated and untreated infected
mice are given. (E) Body temperature determined at the tail skin for B6.Tyr2/2 treated and untreated infected mice over time are given. Data
showed represents the mean of 10 animals and bars represent the SEM.
doi:10.1371/journal.pone.0029493.g004
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cerebral vasculature and in the innate response to the parasite
[47,48] and, in agreement with the literature, our data showed a
positive correlation between platelet count and survival. Last, we
have shown that melanin treatment does not affect survival in P.
berghei ANKA infections, suggesting again that melanin does not
affect the progression of murine CM. Taken together, our data
suggests that melanization was not selected by malaria. In spite of
that, one cannot exclude completely the role of melanin on the
response to malaria, for the mouse and human immune system
and skin are considerably different. For instance, human
melanocytes are mainly found at the basal layer of the epidermis
while mouse melanocytes reside in the hair follicle and the dermis
[49,50], pelage density is much higher in rodents than humans,
and the stratum corneum of rodents is generally more permeable
and fragile [51]. Furthermore mice are nocturnal animals with
very small vitamin D needs, suggesting that melanin must play a
different role in vitamin D metabolism in mice. Humans, on the
other hand, are considered diurnal animals that synthesize vitamin
D in the skin on exposure to UV light [52].
Figure 5. Effect of vitamin D3 treatment on cerebral malaria. (A) The percent of treated and control P. berghei ANKA infected B6 mice that
survived over time is given in Kaplan-Meier curves. Death was defined as a parasitemia $60%, moribundity or death (P=0.76). (B) Parasitemias,
determined by GIEMSA stained smears of tail blood, are given for treated and control B6 mice over time. (C) Clinical scores determined by the
modified SNAP scoring system are given. (D) Hemoglobin concentrations determined on tail blood are given. (E) Body temperature determined at
the tail skin for treated and control B6 mice over time are given. Data showed represents the mean of 10 animals and bars represent the SEM.
doi:10.1371/journal.pone.0029493.g005
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Ethics statement
All experiments were approved by the National Institute of
Allergy and Infectious Diseases Animal Care and Use Committee.
Animals
Male 8–10 week old C57BL/6, B6.VDR[KO] (strain
B6.129S4-Vdr
tm1Mbd/J, stock number 006133) and B6.TYR[KO]
(strain B6(Cg)-Tyr
c-2J/J, stock number 000058) mice were
obtained from The Jackson Laboratories and allowed to acclimate
in the animal facility until the experiment was performed.
B6.VDR[KO] mice were maintained constantly on a 20% lactose
diet (TD 96348, Harlan) to prevent the development of
osteoporosis.
Malaria infections and treatments
Mice were infected with 1610
6 P. berghei ANKA, 1610
6 P.
chabaudi AS or 1610
4 P. yoelii 17XL infected red blood cells
(iRBCs) i.p. Parasites were obtained from donor mice that were
Figure 6. Effect of VDR knockout on cerebral malaria. (A) The percent of B6 and B6.VDR2/2 P. berghei ANKA infected mice that survived over
time is given in Kaplan-Meier curves. Death was defined as a parasitemia $60%, moribundity or death (P=0.38). (B) Parasitemias, determined by
GIEMSA stained smears of tail blood, are given for B6.VDR2/2 and B6 infected mice over time. (C) Clinical scores determined by the modified SNAP
scoring system are given. (D) Hemoglobin concentrations of B6.VDR2/2 and B6 infected mice are given. (E) Body temperature determined at the tail
skin for both B6.VDR2/2 and B6 infected mice over time are given. Data showed represents the mean of 10 animals and bars represent the SEM.
doi:10.1371/journal.pone.0029493.g006
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obtained from Sigma (M0418) and it was initially dissolved in 0.1
NaOH to solubilize it. The solution pH was adjusted to 7.0, it was
centrifuged and then filtered through a 0.45 mM filter before
injection. Animals were injected i.p. daily with 25 mg/kg of
melanin solution or saline. Vitamin D was obtained from Sigma
(Supelco Cholecalciferol (D3) Cat#47763) and it was first
dissolved in 10 mL of 100% ethanol to make a stock solution
(10 mg/mL). The stock was further diluted in 0.02% Tween 80 to
make a working solution (0.1 mg/mL). Animals were injected with
0.5 mg/kg every other day, starting 3 days before infection. A
similar dose of 1,25-dihydroxivitamin D3 was previously shown
not to cause hypercalcemia but to induce splenocyte apoptosis and
enhance sensitivity to other parasites [53]. For the experiment
investigating the role of the vitamin D receptor (VDR) on the
response to cerebral malaria, VDR knockout mice were kept on a
rescue diet rich in calcium, phosphorus and lactose (Harlan
laboratories, stock #TD.96348) to avoid osteoporosis. 10 animals
were used per group in all experiments. In all cases, parasitemia in
infected mice was quantified by examining Giemsa stained thin
blood smears. Hemoglobin concentration was measured daily with
a HemoCue Hb 201+ using blood from the tail tip (,10 mL/day).
Mice that reached 60% parasitemia or that become moribund
were euthanized. All mice were evaluated daily for the presence of
clinical signs of severe malaria using a simple scoring adapted from
the SNAP scoring system [54]. Animals were scored by evaluating
5 categories: interactions/reflex, cage grasp, visual placing, gait/
posture/appearance, and capacity to hold their body weight on a
baton. Each category was divided in 3 levels, varying from 0 to 2,
where 0 represented normal individuals and 2 the worst case for
that particular parameter. Hematology parameters were deter-
mined on day 0 and 5 using a Hemavet 950 FS system (Drew
Scientific).
Statistics
When applicable, statistical analysis of survival was by Log-rank
(Mantel-Cox) test. The survival curves were calculated using the
Kaplan-Meier estimates and the survival curves were compared by
the log-rank test. Continuous variables were analyzed with the
two-sample t-test, where the Bartlett’s test for equal variances was
used to determine whether the use of a pooled variance or unequal
variances was appropriate. Two-sided P values were reported in
the text. P values were considered significant if P,0.05.
Cytokine Quantification
The levels of cytokines in serum samples were quantified using
the Q-Plex Mouse Cytokine Kit (Quansys Biosciences) according
to manufacturer’s instructions.
Supporting Information
Figure S1 Melanization does not change blood compo-
sition in response to severe malaria anemia. Animals were
infected with 1610
4 P. yoelii 17XL iRBCs on day 0. Hematological
parameters were determined in whole blood. White blood cells
(WBC), Red Blood Cells (RBC), Hemoglobin (Hb), Platelets,
Neutrophils, Lymphocytes and Hematocrit are shown. Data
showed represents the mean of 10 animals and bars represent
the SD of the mean.
(TIF)
Figure S2 Melanin does not alter the cytokine profile in
response to cerebral malaria. Cytokine levels before (day 0)
and 5 days after infection using 1610
6 P. berghei ANKA iRBCs are
shown. Data showed represents the mean of 10 animals and bars
represent the SD of the mean.
(TIF)
Figure S3 Melanization does not alter blood composi-
tion in response to chronic malaria. Animals were infected
with 1610
6 P. chabaudi iRBCs on day 0. White blood cells (WBC),
Red Blood Cells (RBC), Hemoglobin (Hb), Platelets, Neutrophils,
Lymphocytes and Hematocrit are shown. Data showed represents
the mean of 10 animals and bars represent the SD of the mean.
(TIF)
Figure S4 Effect of melanin injections on blood compo-
sition in B6.Tyr2/2 animals. Animals were infected with
1610
6 P. berghei ANKA iRBCs on day 0. White blood cells (WBC),
Red Blood Cells (RBC), Hemoglobin (Hb), Platelets, Lympho-
cytes, Neutrophils, Hematocrit and the linear regression of survival
on platelet counts are given. The dashed lines represent the 95%
confidence interval about the regression line. Data showed
represents the mean of 10 animals and bars represent the SD of
the mean.
(TIF)
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